Wildcat Capital Management as of Dec. 31, 2016
Portfolio Holdings for Wildcat Capital Management
Wildcat Capital Management holds 15 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kite Pharma | 48.6 | $106M | 2.4M | 44.84 | |
| CoStar (CSGP) | 16.9 | $37M | 195k | 188.49 | |
| Nantkwest | 11.8 | $26M | 4.5M | 5.72 | |
| Sorrento Therapeutics (SRNE) | 6.3 | $14M | 2.8M | 4.90 | |
| MiMedx (MDXG) | 4.4 | $9.6M | 1.1M | 8.86 | |
| Ipath Sp 500 Vix S/t Fu Etn | 3.8 | $8.2M | 321k | 25.51 | |
| Lpl Financial Holdings (LPLA) | 3.4 | $7.3M | 207k | 35.21 | |
| Communications Sales&leas Incom us equities / etf's | 1.9 | $4.1M | 163k | 25.41 | |
| Ishares Nasdaq Biotech Indx call | 1.3 | $2.8M | 10k | 265.38 | |
| Nanthealth | 1.1 | $2.4M | 239k | 9.94 | |
| Editas Medicine (EDIT) | 0.3 | $671k | 41k | 16.24 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.2 | $456k | 1.7k | 265.27 | |
| Adverum Biotechnologies | 0.0 | $44k | 15k | 2.93 | |
| Intellia Therapeutics (NTLA) | 0.0 | $46k | 3.5k | 12.99 | |
| General Motors Company (GM) | 0.0 | $28k | 800.00 | 35.00 |
